Skip to main content
. Author manuscript; available in PMC: 2016 Jun 28.
Published in final edited form as: Am J Kidney Dis. 2015 Feb 7;65(5):763–772. doi: 10.1053/j.ajkd.2014.12.013

Figure 4.

Figure 4

The standardized cumulative incidence of any cancer among patients with end-stage renal disease (ESRD) undergoing hemodialysis, accounting for the competing risk of death. Time at risk for a cancer diagnosis began at 9 months after dialysis therapy initiation. Figures were stratified by patient characteristics, including: (A) age at dialysis therapy initiation, (B) sex, (C) race, (D) ethnicity, (E) primary cause of ESRD, (F) year of dialysis therapy initiation, and (G) history of kidney transplantation evaluation. Cumulative incidence functions were standardized to the total study population by combining the cumulative incidence function with inverse probability of exposure weights that account for case-mix characteristics (age at dialysis therapy initiation, sex, race, ethnicity, primary cause of ESRD, and year of dialysis therapy initiation) measured at baseline.